0000950170-24-042655.txt : 20240408
0000950170-24-042655.hdr.sgml : 20240408
20240408164515
ACCESSION NUMBER: 0000950170-24-042655
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240404
FILED AS OF DATE: 20240408
DATE AS OF CHANGE: 20240408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fraser Claire
CENTRAL INDEX KEY: 0001382031
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37465
FILM NUMBER: 24830150
MAIL ADDRESS:
STREET 1: C/O BECTON, DICKINSON AND COMPANY
CITY: FRANKLIN LAKES
STATE: NJ
ZIP: 07465
FORMER NAME:
FORMER CONFORMED NAME: Fraser-Liggett Claire
DATE OF NAME CHANGE: 20061122
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seres Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 274326290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 945 9626
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Seres Health, Inc.
DATE OF NAME CHANGE: 20140603
4
1
ownership.xml
4
X0508
4
2024-04-04
0001609809
Seres Therapeutics, Inc.
MCRB
0001382031
Fraser Claire
C/O SERES THERAPEUTICS, INC.
101 CAMBRIDGE PARK DRIVE
CAMBRIDGE
MA
02140
true
false
false
false
false
Stock Option (right to buy
0.76
2024-04-04
4
A
false
60000
0.00
A
2034-04-03
Common Stock
60000
60000
D
The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders.
/s/ Thomas J. DesRosier, Attorney-in-Fact
2024-04-08